STAT

In biotech’s biggest hub, companies open their labs to an unlikely inspector: the city’s veterinarian

She speaks for the lab mice.

CAMBRIDGE, Mass. — Some cities have public advocates. Others have consumer advocates. And education advocates.

But Cambridge is the only city in America that has an advocate for mice, rats and other creatures. She is Dr. Julie Medley, and her official title is Commissioner of Laboratory Animals. In an unlikely position for someone who thought her career would be devoted to treating cats and dogs in a veterinary practice, she wields considerable authority over some of the nation’s biggest pharmaceutical and biotech companies.

Day after day, Medley shows up — unannounced — at labs across this city and gently demands a tour of companies’ animal research facilities. The companies have no choice but to open their doors.

After she puts on protective clothing, including a disposable, tissue-paper-like gown and shoe coverings, employees guide Medley to where tens, thousands, or in some labs, hundreds of thousands of mice and rats live, eat, and sleep. They show her animals’ medical records. Sometimes, by chance, Medley will be there to watch researchers conducting procedures or surgeries.

“I will watch over their shoulder and make them very nervous — that’s not my intention,’’ Medley said in an interview with STAT. “But that’s one of the things I like to see. It’s one thing to read it on paper and it’s another

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks